Maréchal Lucie, Campion Dominique, Hannequin Didier
Département de neurologie, CHU, INSERM EMI 9906, IFRMP, Faculté de Médecine et de Pharmacie, Rouen.
Presse Med. 2003 May 10;32(16):756-63.
TWO SITUATIONS: Familial occurrence of Alzheimer disease is observed in two quite different situations. The more common is the familial aggregation caused by the Apo E4 genotype. Nevertheless, APO E4 as a major risk factor is neither sufficient nor necessary to induce Alzheimer disease. The second possibility are the autosomal dominant forms of Alzheimer disease. Three different genes are concerned. MUTATIONS: The more frequent mutations are found in the Presenilin 1 gene (PS1), mutations in the amyloid precursor protein (APP) are rare and only a few Presenilin 2 gene (PS2) mutations are reported.
The main clinical characteristic of these autosomal dominant forms is an early age of onset below 60. Neuropathology is similar to sporadic cases: senile plaques with A beta peptide as a major component and neurofibrillary tangles containing Tau protein.
The demonstration that both APP, PS1, and PS2 gene mutations enhance the processing of APP to form A beta peptide is a major argument supporting the amyloid hypothesis of Alzheimer disease. This better knowledge of APP and PS1,2 processing and their interactions with binding proteins does permit to develop treatment strategies.
两种情况:阿尔茨海默病的家族性发病见于两种截然不同的情况。较常见的是由载脂蛋白E4(Apo E4)基因型引起的家族聚集。然而,APO E4作为主要风险因素,既不足以也不是引发阿尔茨海默病的必要条件。第二种可能性是阿尔茨海默病的常染色体显性遗传形式。涉及三个不同的基因。突变:在早老素1基因(PS1)中发现的突变更为常见,淀粉样前体蛋白(APP)的突变很少见,仅报道了少数早老素2基因(PS2)突变。
这些常染色体显性遗传形式的主要临床特征是发病年龄早于60岁。神经病理学与散发性病例相似:以β淀粉样肽为主要成分的老年斑和含有Tau蛋白的神经原纤维缠结。
APP、PS1和PS2基因突变均增强APP加工以形成β淀粉样肽,这一证据是支持阿尔茨海默病淀粉样蛋白假说的主要论据。对APP以及PS1、PS2加工过程及其与结合蛋白相互作用的更深入了解确实有助于制定治疗策略。